Please enable JS

July 12th – GHLF testimony and recommendation to FDA on proposed biosimilar to HUMIRA (adalimumab)

7/ 15

ARTICLE DETAILS

AUTHOR: 50SN Staff

DATE: Jul 15, 2016

TAGS:

SHARE ON: Twitter - Facebook - LinkedIn

July 12th – GHLF testimony and recommendation to FDA on proposed biosimilar to HUMIRA (adalimumab)

Click here to listen to Seth’s Testimony

Click Here to view on a separate screen


 

Font Resize